| 1, 10-Phenanthroline-copper, a footprinting reagent for single-stranded regions of RNAs A Mazumder, R Gaynor, DS Sigman Biochemical and biophysical research communications 187 (3), 1503-1509, 1992 | 35 | 1992 |
| 1017O NTC-001: A phase I study to test safety and efficacy of BNT221, a non-engineered neoantigen-specific T cell product, in patients with advanced or metastatic melanoma JSW Borgers, D Lenkala, B McCarthy, V Kohler, S Hymson, K Esaulova, ... Annals of Oncology 34, S619, 2023 | 2 | 2023 |
| 153 NEO-PTC-01 (BNT-221), an autologous neoantigen-specific T-cell product for adoptive cell therapy of metastatic melanoma D Lenkala, J Kohler, B McCarthy, M Nelson, J McGee, D Kallin, J Sridar, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | 1 | 2020 |
| 201 BNT221, an autologous neoantigen-specific T-cell product for adoptive cell therapy of metastatic ovarian cancer C Arieta, D Velez, S Hannes, S Meda, B McCarthy, D Lenkala, D Harjanto, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021 | | 2021 |
| 364 A personal neoantigen vaccine NEO-PV-01 in combination with chemotherapy and pembrolizumab induces broad de novo immune responses in first line, non-squamous NSCLC M Awad, D Spigel, E Garon, S Waqar, A Lisberg, M Moles, J Tepper, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | | 2020 |
| 769 Interim clinical and translational data from NTC-001, a phase I study to evaluate the non-engineered neoantigen-specific T cell product BNT221 in patients with advanced or … JSW Borgers, D Lenkala, B McCarthy, V Kohler, S Hymson, E Jackson, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| A critical role for the TAR element in promoting efficient human immunodeficiency virus type 1 reverse transcription D Harrich, C Ulich, RB Gaynor Journal of virology 70 (6), 4017-4027, 1996 | 109 | 1996 |
| A discrete cis element in the human immunodeficiency virus long terminal repeat mediates synergistic trans activation by cytomegalovirus immediate-early proteins P Ghazal, J Young, E Giulietti, C Demattei, J Garcia, R Gaynor, ... Journal of virology 65 (12), 6735-6742, 1991 | 88 | 1991 |
| A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus disease A Zuiani, CL Dulberger, NS De Silva, M Marquette, YJ Lu, GM Palowitch, ... Cell, 2024 | 2 | 2024 |
| A novel CDK9 inhibitor shows potent antitumor efficacy in preclinical hematologic tumor models T Yin, MJ Lallena, EL Kreklau, KR Fales, S Carballares, R Torrres, ... Molecular cancer therapeutics 13 (6), 1442-1456, 2014 | 101 | 2014 |
| A personal neoantigen vaccine NEO-PV-01 in combination with chemotherapy and pembrolizumab induces broad de novo immune responses in first-line non-squamous NSCLC: Associations … MM Awad, R Govindan, DR Spigel, EB Garon, V Kohler, R Vyasamneni, ... Cancer Research 81 (13_Supplement), 73-73, 2021 | 2 | 2021 |
| A personal neoantigen vaccine, NEO-PV-01, with anti-PD1 induces broad de novo anti-tumor immunity in patients with metastatic melanoma, NSCLC, and bladder cancer PA Ott, R Govindan, A Naing, TW Friedlander, K Margolin, JJ Lin, ... Annals of Oncology 29, viii400, 2018 | 21 | 2018 |
| A phase Ib trial of personalized neoantigen therapy plus anti-PD-1 in patients with advanced melanoma, non-small cell lung cancer, or bladder cancer PA Ott, S Hu-Lieskovan, B Chmielowski, R Govindan, A Naing, ... Cell 183 (2), 347-362. e24, 2020 | 429 | 2020 |
| A role for extracellular matrix binding receptors in regulating hematopoietic growth factor signaling RB Gaynor Proceedings of the National Academy of Sciences 100 (24), 13737-13738, 2003 | 6 | 2003 |
| A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat. L Pearson, J Garcia, F Wu, N Modesti, J Nelson, R Gaynor Proceedings of the National Academy of Sciences 87 (13), 5079-5083, 1990 | 132 | 1990 |
| A two-component expression system that responds to inflammatory stimuli in vivo AW Varley, SM Geiszler, RB Gaynor, RS Munford Nature biotechnology 15 (10), 1002-1006, 1997 | 44 | 1997 |
| A universal MHCII technology platform to characterize antigen-specific CD4+ T cells R Vyasamneni, V Kohler, B Karki, G Mahimkar, E Esaulova, J McGee, ... Cell Reports Methods 3 (1), 2023 | 1 | 2023 |
| AACR cancer progress report 2014 CL Arteaga, PC Adamson, JA Engelman, M Foti, RB Gaynor, ... Clinical cancer research 20 (19_Supplement), S1-S112, 2014 | 74 | 2014 |
| AACR Cancer Progress Report 2014 CPRS Committee, CL Arteaga, PC Adamson, JA Engelman, M Foti, ... Clinical cancer research: an official journal of the American Association …, 2014 | 4 | 2014 |
| Abimiku AG; Franchini G; Aldrich K; Myagkikh M; Markham P; Gard E; Gallo RC; Robert-Guroff M Humoral and cellular immune responses in rhesus macaques infected with human … K Abravaya, JJ Carrino, S Muldoon, HH Lee, Y Adu-Sarkodie, ... AIDS Res Hum Retroviruses 11, 383-93, 1995 | | 1995 |
